ask="21.95"
ask_size="200"
average_daily_volume="376569"
bid="21.05"
bid_size="1200"
book_value="3.21"
change="-1.41"
change_from_200_day_moving_average="7.43"
change_from_50_day_moving_average="2.35"
change_from_52_week_high="-2.52"
change_From_52_week_low="16.06"
change_in_percent="-6.23%"
close="21.23"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.47"
ex_dividend_date="N/A"
float_shares="7129000"
high="22.55"
high_52_weeks="23.75"
last_trade_date="2/17/2017"
last_trade_price="21.23"
last_trade_size="4212"
last_trade_time="4:00pm"
low="21.12"
low_52_weeks="5.17"
market_capitalization="211.30M"
moving_average_200_day="13.80"
moving_average_50_day="18.88"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.43"
open="22.50"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+53.89%"
percent_change_from_50_day_moving_average="+12.48%"
percent_change_from_52_week_high="-10.61%"
percent_change_from_52_week_low="+310.64%"
previous_close="22.64"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.06"
price_per_sales="3986.55"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="3.02"
stock_exchange="NGM"
symbol="ZYNE"
volume="601518"
weeks_range_52="5.17 - 23.75"
